Sule Ashish Anil, Jun Du Qi, Cheong Chin Yee
Department of General Medicine, Vascular Medicine and Hypertension, Tan Tock Seng Hospital, Tan Tock Seng, Singapore.
Int J Angiol. 2017 Jun;26(2):78-82. doi: 10.1055/s-0036-1572416. Epub 2016 Feb 4.
Prospective study with a controlled arm to know if there are variations of measures of arterial stiffness with posture in subjects with hypertension on antihypertensive medications. We studied postural variations of measures of arterial stiffness in 21 subjects with diagnosed hypertension on antihypertensive medications and compared them with 21 normotensive subjects. All subjects underwent pulse-wave analysis on SphygmoCor in the morning between 8 am to 10 am initially in supine and then in sitting position after 3 minutes. Summary measures on demographics, and blood pressure characteristics at sitting and supine positions are obtained. Differences between characteristics at supine and sitting position are compared using nonparametric paired test of Wilcoxon signed-rank test. A value of < 0.05 was accepted as statistically significant. Antihypertensive medications decreased the supine aortic augmentation pressure (AAP) and augmentation index (AI) but not significantly. When subgroups of patients with antihypertensive treatment were analyzed, it was noted that angiotensin-converting enzyme inhibitor and angiotensin receptor blocker group (12) decreased AAP and AI significantly in supine position compared with patients on other antihypertensive medications (9) (-value 0.034 and 0.038, respectively). There was no significant difference in other groups of calcium channel blockers, β-blockers, or diuretics. However, in normotensive control arm, there was an increase in AAP and AI in the supine position. In hypertensive subjects, on antihypertensive, there was reduction in AAP and AI in supine position compared with those of normotensives. The significance of the decrease in AAP and AI in supine position on antihypertensive needs to be studied further.
一项设有对照组的前瞻性研究,旨在了解服用抗高血压药物的高血压患者的动脉僵硬度测量值是否会随体位变化。我们研究了21名确诊为高血压且正在服用抗高血压药物的受试者的动脉僵硬度测量值的体位变化,并将其与21名血压正常的受试者进行比较。所有受试者于上午8点至10点在SphygmoCor上进行脉搏波分析,最初为仰卧位,3分钟后改为坐位。获取了人口统计学的汇总指标以及坐位和仰卧位时的血压特征。使用Wilcoxon符号秩检验的非参数配对检验比较仰卧位和坐位特征之间的差异。P值<0.05被认为具有统计学意义。抗高血压药物降低了仰卧位主动脉增强压(AAP)和增强指数(AI),但不显著。当分析接受抗高血压治疗的患者亚组时,发现与服用其他抗高血压药物的患者(9名)相比,血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂组(12名)在仰卧位时AAP和AI显著降低(P值分别为0.034和0.038)。钙通道阻滞剂、β受体阻滞剂或利尿剂的其他组之间无显著差异。然而,在血压正常的对照组中,仰卧位时AAP和AI有所增加。在服用抗高血压药物的高血压受试者中,仰卧位时AAP和AI较血压正常者降低。仰卧位时AAP和AI降低在抗高血压方面的意义需要进一步研究。